Precipio Inc (NAS:PRPO)
$ 24.31 -1.6 (-6.3%) Market Cap: 43.45 Mil Enterprise Value: 43.43 Mil PE Ratio: 0 PB Ratio: 3.00 GF Score: 51/100

Q4 2024 Precipio Inc Earnings Call Transcript

Mar 31, 2025 / 09:00 PM GMT
Release Date Price: $6.27

Key Points

Positve
  • Precipio Inc (PRPO) achieved its goal of reaching break-even by the end of 2024, with positive adjusted EBITDA and positive cash flow.
  • The company reported a revenue growth of nearly 26% in Q4 2024 compared to the previous year, and a full-year growth of close to 22%.
  • The pathology division exceeded its break-even point for the second consecutive quarter, contributing positively to the company's cash flow.
  • Precipio Inc (PRPO) is focusing on enhancing its distribution strategy, which is expected to accelerate growth through partnerships.
  • The return of Steve Miller as Chief Commercial Officer is anticipated to drive growth in the product division, leveraging his extensive experience in the diagnostic field.
Negative
  • The product division's Q4 revenues remained flat compared to Q3, indicating challenges in converting customer onboarding into revenue.
  • Regulatory changes have caused delays in revenue realization, as new requirements necessitate modifications to products and processes.
  • Equipment and lab process challenges have led to delays in customer onboarding, impacting revenue timelines.
  • Personnel challenges, such as staff turnover in customer labs, have resulted in significant revenue gaps.
  • The company acknowledges the need to better adapt to challenges and increase its customer base to achieve stable growth and provide reliable financial guidance.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PRPO.OQ - Precipio Inc
Q4 2024 Precipio Inc Earnings Call
Mar 31, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Please note that the conference is being recorded.

Statements made during this call contain forward-looking statements about our business. You should not place undue reliance on forward-looking statements as these statements are based upon our current expectations, forecasts, and assumptions and are subject to significant risks and uncertainties.

These statements may be identified by words such as may, will, should, could, expect, intend, plan, anticipate, believe, estimate, predict, potential, forecast, continue, or the negative of these terms or other words or terms of similar meaning.

Risks and uncertainties that could cause our actual results to differ materially from those set forth in any forward-looking statements
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot